期刊
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
卷 61, 期 12, 页码 901-909出版社
SAGE PUBLICATIONS LTD
DOI: 10.1369/0022155413503662
关键词
ASGPR; galactosamine; galactose; human hepatocellular carcinoma (HCC); immunohistochemistry; targeting delivery
类别
资金
- Merck Sharp Dohme Corp.
Human hepatocellular carcinoma (HCC) is the fifth most common cancer in the world. Currently, surgical resection is the only effective treatment for HCC if the tumor is resectable. Small molecule, biologics and siRNA anti-cancer drugs have been explored for the treatment of HCC. Selective targeting to tumor tissue rather than normal liver in HCC patients is still a challenge. Galactosamine-mediated targeting delivery of anti-cancer drugs in the liver has been tested because its receptor, asialoglycoprotein receptor 1 (ASGPR1), is expressed in the liver and not in other human tissues. We examined ASGPR1 expression levels by immunohistochemistry in HCC with different grades. Guidance for a targeting delivery strategy for anti-cancer drugs to HCC is suggested in this report.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据